• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺髓样癌:细针穿刺细胞学诊断的陷阱以及细胞形态学与RET原癌基因突变的关系

Medullary thyroid carcinoma: pitfalls in diagnosis by fine needle aspiration cytology and relationship of cytomorphology to RET proto-oncogene mutations.

作者信息

Chang Tien-Chun, Wu Shih-Lu, Hsiao Yung-Lien

机构信息

Department of Internal Medicine, College of Medicine, National Taiwan University and National Taiwan University Hospital, Taipei.

出版信息

Acta Cytol. 2005 Sep-Oct;49(5):477-82. doi: 10.1159/000326191.

DOI:10.1159/000326191
PMID:16334022
Abstract

OBJECTIVE

To elucidate the pitfalls in the diagnosis of medullary thyroid carcinoma (MTC) by fine needle aspiration cytology (FNAC) and the relationship of cytomorphology to RET proto-oncogene mutations.

STUDY DESIGN

Cytomorphology was reviewed in the fine needle aspiration slides of 34 patients with MTC proven by surgery and pathology. Germline or somatic RET proto-oncogene mutations were determined using polymerase chain reaction-based sequencing in 15 of 34 patients, and the relationship to cytomorphology was evaluated.

RESULTS

Twenty-eight (82.4%) of 34 cases were diagnosed correctly as MTC by FNAC, 3 cases were misdiagnosed as follicular neoplasm and 1 as desmoid, and 2 cases were suspicious for MTC. The main reason for misdiagnosis was overlooking the slight angular shape of the nuclei or atypical changes. In 15 of 34 cases with germline or somatic RET proto-oncogene mutations determined, 10 cases had a germline mutation, and 1 had only a somatic mutation. There were 4 cases that had neither germline nor somatic RET proto-oncogene mutations. Cells with small/round and spindled forms were the predominant findings of codon 918 ATG-->ACG mutation, and cells with small/round and large oval to polygonal forms were the main findings of codon 634 mutations. There were no misdiagnoses in patients with RET proto-oncogene mutations.

CONCLUSION

FNAC is a good diagnostic method for MTC. Codon 918 mutation correlates mainly with small/round and spindled cells and codon 634 with small/round, large oval to polygonal forms.

摘要

目的

阐明细针穿刺细胞学检查(FNAC)诊断甲状腺髓样癌(MTC)的陷阱以及细胞形态学与RET原癌基因突变的关系。

研究设计

回顾性分析34例经手术及病理证实为MTC患者的细针穿刺涂片的细胞形态学。采用基于聚合酶链反应的测序法对34例患者中的15例进行种系或体细胞RET原癌基因突变检测,并评估其与细胞形态学的关系。

结果

34例中28例(82.4%)经FNAC正确诊断为MTC,3例误诊为滤泡性肿瘤,1例误诊为硬纤维瘤,2例可疑为MTC。误诊的主要原因是忽略了细胞核的轻微角形或非典型变化。在检测的34例种系或体细胞RET原癌基因突变的病例中,10例有种系突变,1例只有体细胞突变。有4例既没有种系也没有体细胞RET原癌基因突变。小/圆形和梭形细胞是密码子918 ATG→ACG突变的主要表现,小/圆形和大椭圆形至多边形细胞是密码子634突变的主要表现。RET原癌基因突变的患者无误诊情况。

结论

FNAC是诊断MTC的一种良好方法。密码子918突变主要与小/圆形和梭形细胞相关,密码子634与小/圆形、大椭圆形至多边形细胞相关。

相似文献

1
Medullary thyroid carcinoma: pitfalls in diagnosis by fine needle aspiration cytology and relationship of cytomorphology to RET proto-oncogene mutations.甲状腺髓样癌:细针穿刺细胞学诊断的陷阱以及细胞形态学与RET原癌基因突变的关系
Acta Cytol. 2005 Sep-Oct;49(5):477-82. doi: 10.1159/000326191.
2
The relationship of cytomorphology of medullary thyroid carcinomas between family members with the same RET proto-oncogene mutation.具有相同RET原癌基因突变的甲状腺髓样癌家族成员之间的细胞形态学关系。
Acta Cytol. 2011;55(6):556-62. doi: 10.1159/000333246. Epub 2011 Dec 9.
3
Fine-needle aspiration cytology for medullary thyroid carcinoma: a single institutional experience in Japan.甲状腺髓样癌的细针穿刺细胞学检查:日本单机构经验
Endocr J. 2017 Nov 29;64(11):1099-1104. doi: 10.1507/endocrj.EJ17-0238. Epub 2017 Sep 5.
4
Paraganglioma-like medullary thyroid carcinoma: fine needle aspiration cytology features with histological correlation.副神经节瘤样甲状腺髓样癌:细针穿刺细胞学特征及其与组织学的相关性
Cytopathology. 2009 Jun;20(3):188-94. doi: 10.1111/j.1365-2303.2008.00580.x. Epub 2008 Jul 9.
5
A case of metastatic medullary thyroid carcinoma: early identification before surgery of an RET proto-oncogene somatic mutation in fine-needle aspirate specimens.一例转移性甲状腺髓样癌:细针穿刺抽吸标本中RET原癌基因体细胞突变在手术前的早期鉴定。
J Clin Endocrinol Metab. 1997 Oct;82(10):3378-82. doi: 10.1210/jcem.82.10.4278.
6
Medullary Thyroid Carcinoma Associated with Germline RET Mutation.与种系RET突变相关的甲状腺髓样癌
Thyroid. 2016 Dec;26(12):1744-1751. doi: 10.1089/thy.2016.0374. Epub 2016 Oct 18.
7
High prevalence of RAS mutations in RET-negative sporadic medullary thyroid carcinomas.RET 阴性散发性甲状腺髓样癌中 RAS 突变的高发生率。
J Clin Endocrinol Metab. 2011 May;96(5):E863-8. doi: 10.1210/jc.2010-1921. Epub 2011 Feb 16.
8
Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma.散发性甲状腺髓样癌中RET原癌基因的体细胞突变。
Clin Endocrinol (Oxf). 1996 Mar;44(3):249-57. doi: 10.1046/j.1365-2265.1996.681503.x.
9
Analysis of inherited genetic variants in ret proto-oncogene of Brazilian patients with apparently sporadic medullary thyroid carcinoma.对巴西明显散发型甲状腺髓样癌患者RET原癌基因中遗传变异的分析。
Thyroid. 2006 Jan;16(1):9-15. doi: 10.1089/thy.2006.16.9.
10
New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.87岁伴有高危RET原癌基因密码子620突变的家族性甲状腺髓样癌新病例报告
J Laryngol Otol. 2009 Jul;123(7):796-800. doi: 10.1017/S0022215108003472. Epub 2008 Sep 4.

引用本文的文献

1
The diagnostic challenges of medullary thyroid carcinoma: A practical guide for cytopathologists.甲状腺髓样癌的诊断挑战:细胞病理学家实用指南。
Cancer Cytopathol. 2025 Jun;133(6):e70023. doi: 10.1002/cncy.70023.
2
The Co-Occurrence of Medullary and Papillary Thyroid Carcinoma-A Literature Review Based on a Case Report.髓样甲状腺癌与乳头状甲状腺癌的同时发生——基于一例病例报告的文献综述
Case Rep Endocrinol. 2024 Oct 17;2024:2393186. doi: 10.1155/2024/2393186. eCollection 2024.
3
Calcitonin levels in washout samples vs. cytology in the detection of malignant lymph node metastasis in recurrent medullary thyroid cancer.
降钙素水平在洗脱样本与细胞学检查在复发性甲状腺髓样癌中恶性淋巴结转移的检测。
Turk J Med Sci. 2021 Dec 13;51(6):3061-3066. doi: 10.3906/sag-2105-280.
4
Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules.降钙素检测用于甲状腺结节患者髓样甲状腺癌的检测。
Cochrane Database Syst Rev. 2020 Mar 16;3(3):CD010159. doi: 10.1002/14651858.CD010159.pub2.
5
Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines.甲状腺髓样癌的诊断与病理特征——现行指南综述
Curr Oncol. 2019 Oct;26(5):338-344. doi: 10.3747/co.26.5539. Epub 2019 Oct 1.
6
A pioneering RET genetic screening study in the State of Ceará, Brazil, evaluating patients with medullary thyroid cancer and at-risk relatives: experience with 247 individuals.巴西塞阿拉州一项开创性的RET基因筛查研究,评估甲状腺髓样癌患者及其高危亲属:247例个体的经验。
Arch Endocrinol Metab. 2018;62(6):623-635. doi: 10.20945/2359-3997000000088.
7
Calcitonin measurement in fine-needle aspirate washout fluid by electrochemiluminescence immunoassay for thyroid tumors.通过电化学发光免疫分析法检测甲状腺肿瘤细针穿刺冲洗液中的降钙素
Thyroid Res. 2018 Oct 30;11:15. doi: 10.1186/s13044-018-0059-4. eCollection 2018.
8
Multikinase Inhibitors for the Treatment of Progressive, Metastatic Medullary Thyroid Cancer - An Evolving Paradigm.用于治疗进展性、转移性甲状腺髓样癌的多激酶抑制剂——一种不断演变的模式
Eur Endocrinol. 2014 Aug;10(2):145-150. doi: 10.17925/EE.2014.10.02.145. Epub 2014 Aug 28.
9
Thyroid Fine-Needle Aspiration in Taiwan: The History and Current Practice.台湾的甲状腺细针穿刺:历史与当前实践
J Pathol Transl Med. 2017 Nov;51(6):560-564. doi: 10.4132/jptm.2017.09.20. Epub 2017 Oct 18.
10
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.美国甲状腺协会修订的甲状腺髓样癌管理指南。
Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335.